Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.4.1.2 (
acetyl-CoA carboxylase
)
2,876
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Germ line alterations in
BRCA1
(breast cancer susceptibility gene 1) are associated with an increased susceptibility to breast and ovarian cancer.
BRCA1
acts as a scaffold protein implicated in multiple cellular functions, such as transcription, DNA repair, and ubiquitination. However, the molecular mechanisms responsible for tumorigenesis are not yet fully understood. We have recently demonstrated that
BRCA1
interacts in vivo with
acetyl coenzyme A carboxylase
alpha (ACCA) through its tandem of
BRCA1
C terminus (BRCT) domains. To understand the biological function of the
BRCA1
.ACCA complex, we sought to determine whether
BRCA1
is a regulator of lipogenesis through its interaction with ACCA. We showed here that RNA inhibition-mediated down-regulation of
BRCA1
expression induced a marked increase in the fatty acid synthesis. We then delineated the biochemical characteristics of the complex and found that
BRCA1
interacts solely with the phosphorylated and inactive form of ACCA (P-ACCA). Finally, we demonstrated that
BRCA1
affects lipid synthesis by preventing P-ACCA dephosphorylation. These results suggest that
BRCA1
affects lipogenesis through binding to P-ACCA, providing a new mechanism by which
BRCA1
may exert a tumor suppressor function.
...
PMID:BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase. 1632 98